Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

AstraZeneca AZ

AZ adds gout drug Zurampic to asset sale

Ironwood Pharmaceuticals buys exclusive US rights to the therapy and follow-up product

Eli Lilly HQ

Lilly’s psoriasis drug Taltz cleared in Europe

Clinicians suggest the IL-17 inhibitor has “best-in-class data”

- PMLiVE

Astellas names Bob Chib to development leadership role

He takes up corporate strategy and planning position

- PMLiVE

Gyros Protein Technologies appoints Asia-Pacific VP

Peter Luk tasked with driving the company’s expansion in the region

- PMLiVE

Stories that can save lives

“Sometimes reality is too complex. Stories give it form.”

Why digital communication means leaving no customer behind

You don’t have to accept that only a small percentage of your customers will ever get the full information about your product.

Anthill Agency

- PMLiVE

Valeant appoints Joseph Papa to end CEO uncertainty

He will take over from Michael Pearson at the troubled pharma company in May

- PMLiVE

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

EAGLES trial of 8,000 patients backs the smoking cessation drugs' safety

- PMLiVE

Gilead bags EU approval for next-generation HIV drug

Descovy expected to replace Truvada as the firm’s lead antiviral blockbuster

Matthew Simas joins Truveris board of directors

He brings experience from Alliance Health and IMS Health

- PMLiVE

Does safety sell medicines?

Is pharmacovigilance unnecessary policing or a strategic asset for pharma companies?

National Institute for Health and Care Excellence NICE logo

NICE changes tack on Sanofi’s prostate cancer drug Jevtana

Approves the therapy for NHS use after accepting undisclosed additional discount 

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links